Plain-English translation of NCT07919457 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a personalized approach to managing chronic pain that develops after head and neck cancer treatment. Rather than using a one-size-fits-all strategy, doctors will first identify what type of pain you're experiencing, then create a treatment plan specifically for you. This customized plan might include medications, targeted injections, or nerve blocks—whatever is most likely to help your particular pain.
Many people who finish head and neck cancer treatment continue to live with chronic pain that significantly affects their quality of life. This trial exists to see whether tailoring pain treatment to each person's specific pain pattern—rather than offering generic treatments—can provide much better relief.
You likely qualify if…
You likely don't qualify if…
You will attend three visits over one month (at the start, 2 weeks in, and 4 weeks in). At these visits, you'll complete questionnaires about your pain, mood, and medication use, and have a detailed exam to pinpoint your pain type. Based on those findings, you'll receive a personalized treatment plan—which might include medications, injections, or nerve blocks. Throughout the month, you'll track how well the treatment is working and report any side effects.
AI-generated summary from trial data · Nov 17, 2026 · Not medical advice
Pakistan